Comparison of various lazaroid compounds for protection against ischemic liver injury.
Ishizaki
N
N
Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pennsylvania 15213, USA.
Zhu
Y
Y
Zhang
S
S
Nemoto
A
A
Kobayashi
Y
Y
Subbotin
V M
VM
Lee
R G
RG
Starzl
T E
TE
Todo
S
S
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001219:Aspartate Aminotransferases / Q000097:blood; D004285:Dogs; D005260:Female; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007262:Infusions, Intravenous; D007511:Ischemia / Q000517:prevention & control*; D008099:Liver / Q000098:blood supply* / Q000502:physiology; D009926:Organ Preservation / Q000379:methods*; D011281:Pregnatrienes / Q000008:administration & dosage / Q000494:pharmacology*; D015427:Reperfusion Injury / Q000517:prevention & control*
D000975:Antioxidants; D007166:Immunosuppressive Agents; D011281:Pregnatrienes; C074965:U 74389F; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; C053356:U 74500A; C053355:tirilazad